Overview of preparedness and response to COVID-19 in Ghana.
COVID-19
Ghana
Response
pandemic
preparedness
Journal
Ghana medical journal
ISSN: 2616-163X
Titre abrégé: Ghana Med J
Pays: Ghana
ID NLM: 0073210
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
entrez:
2
3
2022
pubmed:
3
3
2022
medline:
4
3
2022
Statut:
ppublish
Résumé
The Coronavirus disease 2019 (COVID-19) outbreak in Ghana is part of an ongoing pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The first two cases of COVID-19 were confirmed in Ghana on 12th March 2020. COVID-19 was consequently declared a Public Health Emergency of National Concern, triggering several response actions, including enhanced surveillance, case detection, case management and contact tracing, closure of borders, suspension of international flights, ban on social gatherings and closure of schools. Preparedness and response plans were activated for implementation at the national, regional, district and community levels. Ghana's Strategic approaches were to limit and stop the importation of cases; detect and contain cases early; expand infrastructure, logistics and capacity to provide quality healthcare for the sick; minimise disruption to social and economic life and increase the domestic capacity of all sectors to deal with existing and future shocks. The health sector strategic frame focused on testing, treatment, and tracking. As of 31st December 2020, a total of 535,168 cases, including 335 deaths (CFR: 0.61%), have been confirmed with 53,928 recoveries and 905 active cases. All the regions have reported cases, with Greater Accra reporting the highest number. The response actions in Ghana have seen high-level political commitment, appropriate and timely decisions, and a careful balance of public health interventions with economic and socio-cultural dynamics. Efforts are ongoing to intensify non-pharmaceutical interventions, sustain the gains made so far and introduce COVID-19 vaccines to reduce the public health burden of the disease in Ghana. None declared.
Identifiants
pubmed: 35233113
doi: 10.4314/gmj.v55i2s.6
pii: jGMJ.v55.i2s.pg38
pmc: PMC8853692
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
38-47Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MR/J01477X/1
Pays : United Kingdom
Informations de copyright
Copyright © The Author(s).
Déclaration de conflit d'intérêts
Conflict of interest: None declared
Références
JAMA. 2020 Apr 21;323(15):1499-1500
pubmed: 32159735
N Engl J Med. 2020 Oct 29;383(18):1757-1766
pubmed: 32329974
Lancet. 2020 Mar 21;395(10228):e52
pubmed: 32171074
BMC Med. 2020 Feb 28;18(1):57
pubmed: 32106852
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814
Rev Med Virol. 2021 May;31(3):e2179
pubmed: 33035373
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):407-412
pubmed: 32335367
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Cell Biosci. 2020 Mar 16;10:40
pubmed: 32190290
AJR Am J Roentgenol. 2020 Jul;215(1):87-93
pubmed: 32174129